Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...

A new study shows the potential of an MOF to capture CO2 with strong low-pressure uptake and efficient regeneration under mild conditions.

The modern-day Jets are perfectly average drafters but below average at development. Bruce Bennett / Winnipeg’s playoff hopes fade by the day, so it’s no surprise this mailbag was filled with ...

VIS-101 targets VEGF-A and ANG-2 with a bispecific tetravalent format designed to increase ligand affinity and binding capacity, aiming to improve anatomic/visual outcomes and extend dosing intervals.

Imagine, a trusted partner to the world’s most successful brands, today announced the release of its latest thought leadership report, Trends & Inspiration: Q1 2026 – Where Convenience Meets Care, ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

Scientists analyzed the urine of wild chimpanzees who'd feasted on fallen fruit to see how much alcohol they consumed from ...

On the night of March 5, Columbia University’s Institute for Research in African American Studies co-hosted an emergency forum on what is happening to Black-studies departments ...

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

Radiopharm Theranostics maintains a "Hold" rating as its radiotherapeutic pipeline advances, with key data readouts expected in 2026. Click here to read.

Investigational RGX-202 continues to demonstrate evidence of positively changing disease trajectory for Duchenne Pivotal dose participants exceeded external controls across functional ...